Peter H. Kraus

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

Carsten Saft, Jochen Zange, Jürgen Andrich et al. · Movement Disorders · 2005 · 180 citations

Life Sciences, Genetics, Neuroscience +14

Riluzole in Huntington's disease: a 3‐year, randomized controlled study

G. Bernhard Landwehrmeyer, Bruno Dubois, Justo Garcı́a de Yébenes et al. · Annals of Neurology · 2007 · 177 citations · Full text

Medicine, Neurology, Pharmacology +14

Anhedonia, Depression, and Motor Functioning in Parkinson’s Disease During Treatment With Pramipexole

Matthias Lemke, H. M. Brecht, Juergen Koester et al. · Journal of Neuropsychiatry · 2005 · 159 citations

Medicine, Pharmacology, Psychiatry +17

Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at‐home testing device

Christopher G. Goetz, Glenn T. Stebbins, David Wolff et al. · Movement Disorders · 2008 · 155 citations · Full text

Medicine, Health Informatics, Neurology +17

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Larissa Arning, Peter H. Kraus, Sandra Valentin et al. · Neurogenetics · 2004 · 112 citations

Life Sciences, Genetics, Molecular Genetics +12